Your browser doesn't support javascript.
loading
Therapeutic role of rifampicin in Alzheimer's disease.
Yulug, Burak; Hanoglu, Lütfü; Ozansoy, Mehmet; Isik, Dogan; Kilic, Ulkan; Kilic, Ertugrul; Schabitz, Wolf Rüdiger.
Afiliación
  • Yulug B; Department of Neurology, Istanbul Medipol University, Istanbul, Turkey.
  • Hanoglu L; Department of Restorative and Regenerative Medicine, Istanbul Medipol University, Istanbul, Turkey.
  • Ozansoy M; Department of Neurology, Istanbul Medipol University, Istanbul, Turkey.
  • Isik D; Department of Restorative and Regenerative Medicine, Istanbul Medipol University, Istanbul, Turkey.
  • Kilic U; Department of Restorative and Regenerative Medicine, Istanbul Medipol University, Istanbul, Turkey.
  • Kilic E; Department of Physiology, International School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
  • Schabitz WR; Department of Psychiatry, Istanbul Medipol University, Istanbul, Turkey.
Psychiatry Clin Neurosci ; 72(3): 152-159, 2018 Mar.
Article en En | MEDLINE | ID: mdl-29315976
Rifampicin exerts significant brain protective functions in multiple experimental models. Here we summarize the underlying mechanisms of the neuroprotective and pro-cognitive effects of rifampicin that are mediated by its anti-inflammatory, anti-tau, anti-amyloid, and cholinergic effects. Beyond suggesting that rifampicin shows strong brain protective effects in preclinical models of Alzheimer's disease, we also provide substantial clinical evidence for the neuroprotective and pro-cognitive effects of rifampicin. Future neuroimaging studies combined with clinical assessment scores are the following steps to be taken in this field of research.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rifampin / Nootrópicos / Fármacos Neuroprotectores / Enfermedad de Alzheimer Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Psychiatry Clin Neurosci Asunto de la revista: NEUROLOGIA / PSIQUIATRIA Año: 2018 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rifampin / Nootrópicos / Fármacos Neuroprotectores / Enfermedad de Alzheimer Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Psychiatry Clin Neurosci Asunto de la revista: NEUROLOGIA / PSIQUIATRIA Año: 2018 Tipo del documento: Article País de afiliación: Turquía